146 related articles for article (PubMed ID: 35397077)
1. Long-term outcomes of whole gland high-intensity focused ultrasound for localized prostate cancer.
Lo Verde K; Toledano H; Campagna J; Rossi D; Bastide C; Baboudjian M
Int Urol Nephrol; 2022 Jun; 54(6):1233-1238. PubMed ID: 35397077
[TBL] [Abstract][Full Text] [Related]
2. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
3. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
[TBL] [Abstract][Full Text] [Related]
4. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
5. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
6. Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: Medium-term results from a single centre.
Wu YT; Chiang PH
PLoS One; 2020; 15(7):e0236026. PubMed ID: 32701978
[TBL] [Abstract][Full Text] [Related]
7. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Reddy D; Peters M; Shah TT; van Son M; Tanaka MB; Huber PM; Lomas D; Rakauskas A; Miah S; Eldred-Evans D; Guillaumier S; Hosking-Jervis F; Engle R; Dudderidge T; Hindley RG; Emara A; Nigam R; McCartan N; Valerio M; Afzal N; Lewi H; Orczyk C; Ogden C; Shergill I; Persad R; Virdi J; Moore CM; Arya M; Winkler M; Emberton M; Ahmed HU
Eur Urol; 2022 Apr; 81(4):407-413. PubMed ID: 35123819
[TBL] [Abstract][Full Text] [Related]
8. Oncological Long-term Outcome After Whole-gland High-intensity Focused Ultrasound for Prostate Cancer-21-yr Follow-up.
Bründl J; Osberghaus V; Zeman F; Breyer J; Ganzer R; Blana A; Gierth M; Denzinger S; Burger M; Rosenhammer B
Eur Urol Focus; 2022 Jan; 8(1):134-140. PubMed ID: 33483288
[TBL] [Abstract][Full Text] [Related]
9. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients.
Crouzet S; Blana A; Murat FJ; Pasticier G; Brown SCW; Conti GN; Ganzer R; Chapet O; Gelet A; Chaussy CG; Robertson CN; Thuroff S; Ward JF
BJU Int; 2017 Jun; 119(6):896-904. PubMed ID: 28063191
[TBL] [Abstract][Full Text] [Related]
10. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy.
Uddin Ahmed H; Cathcart P; Chalasani V; Williams A; McCartan N; Freeman A; Kirkham A; Allen C; Chin J; Emberton M
Cancer; 2012 Jun; 118(12):3071-8. PubMed ID: 22071795
[TBL] [Abstract][Full Text] [Related]
11. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.
Hostiou T; Gelet A; Chapelon JY; Rouvière O; Mège-Lechevalier F; Lafon C; Tonoli-Catez H; Badet L; Crouzet S
BJU Int; 2019 Nov; 124(5):746-757. PubMed ID: 31148367
[TBL] [Abstract][Full Text] [Related]
12. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.
Ganzer R; Fritsche HM; Brandtner A; Bründl J; Koch D; Wieland WF; Blana A
BJU Int; 2013 Aug; 112(3):322-9. PubMed ID: 23356910
[TBL] [Abstract][Full Text] [Related]
13. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
14. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
[TBL] [Abstract][Full Text] [Related]
15. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
16. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
[TBL] [Abstract][Full Text] [Related]
17. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
[TBL] [Abstract][Full Text] [Related]
18. Salvage high-intensity focused ultrasound (S-HIFU) for recurrence after primary radiotherapy of prostate cancer.
Long Depaquit T; Campagna J; Bastide C; Baboudjian M; Corral R; Uleri A; Toledano H
Fr J Urol; 2024 Mar; 34(5):102633. PubMed ID: 38547931
[TBL] [Abstract][Full Text] [Related]
19. Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Whelan K; Shayegan B; Orovan WL
BJU Int; 2012 Oct; 110(8):1142-8. PubMed ID: 22372721
[TBL] [Abstract][Full Text] [Related]
20. Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes.
Komura K; Inamoto T; Masuda H; Watsuji T; Azuma H
Acta Biomed; 2012 Dec; 83(3):189-96. PubMed ID: 23762994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]